This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pharma Projects, I. Hutton (ed.), PJB Publications, London.
Bienz-Tadmor, B., Dicerbo, P.A., Tadmor, G. and Lasagna, L. 1992. Biopharmaceuticals and conventional drugs: Clinical success rates. Bio/Technology 10: 521–525.
Halliday, R.G., Walker, S.R. and Lumley, C.E. 1992. R&D philosophy and management in the world's leading pharmaceutical companies. J. Pharm. Med. 2: 139–154.
Shaffer, M. 1992. Drugs approved in 1991. FDA Talk Paper (Jan. 15, 1992), Food and Drug Administration, U. S. Department of Health and Human Services.
Miller, H.I. 1992. Drug approvals. Nature 356: 189.
Scrip. 1993. EC concertation progress reviewed. Scrip 1850: 7.
Bienz-Tadmor, B. 1993. Biopharmaceuticals go to market: Patterns of worldwide development. Bio/Technology 11: 168–172.
Reis-Arndt, E. 1993. Neue pharmazeutische Wirkstoffe 1961-1990. Pharm. Ind. 55: 14–21.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Struck, MM. Biopharmaceutical R&D Success Rates and Development Times. Nat Biotechnol 12, 674–677 (1994). https://doi.org/10.1038/nbt0794-674
Issue Date:
DOI: https://doi.org/10.1038/nbt0794-674